The latest biotech news

News and Trends 5 Aug 2016

Dutch FF Pharma has a Promising Immunotherapy to fight Crohn’s Disease

Arrivederci Italia! We’re going to fly up to the Netherlands for another Biotech-related adventure! This time, we’re visiting Utrecht, the fourth most populated city in the country and home-base to FF Pharma, our Biotech of the Week! City: Utrecht (The Netherlands) Founded: 2012 Employees: N/A Financial Data: €4M Total Raised (as of 12/2015) CEO: Mark De Boer Mission: FF […]

August 5, 2016 - 2 minutesmins - By Joachim Eeckhout

News and Trends 4 Aug 2016

Roche drops Partnership for Hepatitis Immunotherapy

While everybody wants to get the next immunotherapy on the market, Roche is turning its back on one. It’s leaving the partnership with Inovio, which focuses on developing a DNA-based immunotherapy to treat Hepatitis B. Previously, Roche has left projects to focus on immunotherapies, particularly in the hype field of immuno-oncology. This was an important […]

August 4, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 4 Aug 2016

Marine Drug goes to Phase III trials to treat Lung Cancer

PharmaMar is starting a new Phase III trial, with patients suffering from small cell lung cancer (SCLC). It’ll test the efficacy of its third candidate obtained from marine organisms (PM1183) as a SCLC treatment. PharmaMar is one of the hot Biotechs in Spain, which just saw its second drug finish Phase III trials with good results (and is […]

August 4, 2016 - 2 minutesmins - By Denise Neves Gameiro

cambridge famin C13orf31 macrophage metabolism

News and Trends 3 Aug 2016

Mysterious Immunology Mechanism Unlocked thanks to CRISPR

While studying a mutation connected to inflammatory disease, researchers from the University of Cambridge have found a previously unknown mechanism in immune response. As the cost of NGS plummets, genetic data is growing massively. With the help of bioinformatics, information about genetic variants and mutations can be linked to diseases. Sophia Genetics (Switzerland), Diploid (Belgium) […]

August 3, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 3 Aug 2016

UPDATED: TiGenix finishes Phase III Stem Cell therapy to treat Crohn’s disease

Belgium is a real pioneer in developing stem cell therapies. TiGenix pushes this precursor position even further by presenting good results from a Phase III of its stem cell therapy (Cx601) treating Crohn’s disease. UPDATE (article originally published on 24/8/2015): TiGenix’s Phase III results were now published in The Lancet. Julián Panés, the global coordinator […]

August 3, 2016 - 3 minutesmins - By Philip Hemme

galvani bioelectronics electroceuticals gsk verily google

News and Trends 2 Aug 2016

Google and GSK invest €630M to create a new Bioelectronics Champion

GSK and Verily Life Sciences are creating a new company together, Galvani Bioelectronics. Along with €630M in investment, it’ll inherit intellectual property to pioneer a new class of therapies – bioelectronic medicines. GSK is one of the big Pharma based in Europe and has had a strong presence in many hype fields of medical Biotech. Examples are […]

August 2, 2016 - 3 minutesmins - By Denise Neves Gameiro

microbiome therapies seres therapeutics ser 009

News and Trends 2 Aug 2016

Microbiome Therapies suffer setback with a Phase II Failure

The hype field of the Microbiome could be taking a step back, as the most advanced program has failed to meet its primary endpoint in a Phase II trial. What does this mean for the emerging class of therapies? As we have seen at Refresh’s Microbiome fireside chat, the field took really big steps in its recent […]

August 2, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 1 Aug 2016

Biotech producer of Vaccines goes public on Nasdaq Stockholm

After raising €2M in its successful IPO, ExpreS2ion Biotech starts trading on Nasdaq First North in Stockholm – a real milestone for this industrial spin-out. Expres2ion Biotech started out in 2010, as a spin-out of a Danish company focused on human antibodies, Affitech. Affitech itself has had a convoluted path. It was initially Norwegian, then merging with […]

August 1, 2016 - 2 minutesmins - By Denise Neves Gameiro

oxitec aedes aegypti grand cayman zika dengue

News and Trends 1 Aug 2016

The Cayman Islands will now also release GM Mosquitoes against Zika Virus

A court finally allowed the release of Oxitec‘s ‘friendly’ mosquitoes in the Grand Cayman (1 of the 3 islands). If the technique repeats its recent successes, the local population of Zika-transmitting species could decrease by 90%. Located in the tropics, the Cayman Islands are one of the territories at risk of the spread of Aedes […]

August 1, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 29 Jul 2016

Gene Therapy for severe Hemophilia has new Phase I/II Results

uniQure has new data from the Phase I/II trial of its gene therapy for Hemophilia B, a rare genetic disorder. After 9 months, the therapy maintains 75% reduction of transfusions. A good sign for the therapy’s durability. Although quite rare (1 in 20,000 male births), Hemophilia B is famous for being spread in European royal […]

July 29, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 29 Jul 2016

Polish Selvita’s Inflammation Research used to start new Biotech in Scotland

The new Biotech Nodthera will be based in Edinburgh and focus on the discovery and development of novel small molecule candidates to treat inflammation in a range of autoimmune diseases. Founded by Epidarex Capital, it will work alongside Selvita (Poland) in a series of deals worth up to €6.35M. The technology behind Nodthera’s focus is built on […]

July 29, 2016 - 3 minutesmins - By Dani Bancroft

News and Trends 29 Jul 2016

Philogen targets Angiogenesis for cancer and Autoimmune Therapies

Barcelona was pleasant but once again it’s time to go away! We won’t go far… we’re just crossing the Balearic sea to the shores of Italy and visit Sovicille, a suburban town not far from Sienna, where Swiss-Italian company Philogen, our Biotech of the Week, is based! City: Sovicille (Italy) Founded: 1996 Employees: 70 Financial Data: N/A CEO: Duccio […]

July 29, 2016 - 2 minutesmins - By Joachim Eeckhout

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

News and Trends

Dutch FF Pharma has a Promising Immunotherapy to fight Crohn’s Disease

Roche drops Partnership for Hepatitis Immunotherapy

Marine Drug goes to Phase III trials to treat Lung Cancer

Mysterious Immunology Mechanism Unlocked thanks to CRISPR

UPDATED: TiGenix finishes Phase III Stem Cell therapy to treat Crohn’s disease

Google and GSK invest €630M to create a new Bioelectronics Champion

Microbiome Therapies suffer setback with a Phase II Failure

Biotech producer of Vaccines goes public on Nasdaq Stockholm

The Cayman Islands will now also release GM Mosquitoes against Zika Virus

Gene Therapy for severe Hemophilia has new Phase I/II Results

Polish Selvita’s Inflammation Research used to start new Biotech in Scotland

Philogen targets Angiogenesis for cancer and Autoimmune Therapies

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!